Jia Jie Biomedical Co Ltd Total Liabilities
Jia Jie Biomedical Co Ltd total liabilities. Based on the latest financial reports, Jia Jie Biomedical Co Ltd (4109) has total liabilities worth NT$220.89 Million TWD (≈ $6.96 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jia Jie Biomedical Co Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Jia Jie Biomedical Co Ltd (2015–2025)
Total liabilities of Jia Jie Biomedical Co Ltd from 2015 to 2025. This chart illustrates how Jia Jie Biomedical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore how much of Jia Jie Biomedical Co Ltd's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Jia Jie Biomedical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Jia Jie Biomedical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
East Asia Holdings Investment Limited
KQ:900110
|
Korea | ₩18.88 Billion |
|
RENALYTIX PLC LS-0025
F:2O9
|
Germany | €11.10 Million |
|
Sinsin Pharmaceutical Co. Ltd
KQ:002800
|
Korea | ₩65.10 Billion |
|
RFTech Co. Ltd
KQ:061040
|
Korea | ₩203.65 Billion |
|
Dish TV India Limited
NSE:DISHTV
|
India | Rs57.40 Billion |
|
TradeDoubler AB
ST:TRAD
|
Sweden | Skr680.21 Million |
|
Xos Inc
NASDAQ:XOS
|
USA | $31.59 Million |
Liability Composition Analysis (2015–2025)
This chart breaks down Jia Jie Biomedical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see total assets of Jia Jie Biomedical Co Ltd.
Liquidity & Leverage Metrics
Jia Jie Biomedical Co Ltd Total Liabilities Ratios Explained
Jia Jie Biomedical Co Ltd total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.08 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.13 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.11 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Jia Jie Biomedical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Jia Jie Biomedical Co Ltd (2015–2025)
The table below shows the annual total liabilities of Jia Jie Biomedical Co Ltd from 2015 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$174.89 Million ≈ $5.51 Million |
+42.09% |
| 2024-12-31 | NT$123.08 Million ≈ $3.88 Million |
-64.08% |
| 2023-12-31 | NT$342.69 Million ≈ $10.80 Million |
+328.38% |
| 2022-12-31 | NT$80.00 Million ≈ $2.52 Million |
-7.48% |
| 2021-12-31 | NT$86.47 Million ≈ $2.72 Million |
+6.17% |
| 2020-12-31 | NT$81.44 Million ≈ $2.57 Million |
-49.39% |
| 2019-12-31 | NT$160.92 Million ≈ $5.07 Million |
-60.21% |
| 2018-12-31 | NT$404.40 Million ≈ $12.74 Million |
-34.94% |
| 2017-12-31 | NT$621.58 Million ≈ $19.58 Million |
-9.25% |
| 2016-12-31 | NT$684.91 Million ≈ $21.58 Million |
+14.95% |
| 2015-12-31 | NT$595.84 Million ≈ $18.77 Million |
-- |
About Jia Jie Biomedical Co Ltd
Jia Jie Biomedical Co., Ltd. produces and sells health foods in Taiwan and Mainland China. It operates through two segments: Nutritional Health Products and Insurance Brokerage. The company engages in the processing, sale, and trading of softshell turtle food; manufacture of dairy products; miscellaneous food manufacturing, such as softshell turtle egg powder capsules, enzyme powder, tortoise jel… Read more